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Abstract
The regulation of food intake is a complex mechanism, and the hypothalamus is
the main central structure implicated. In particular, the arcuate nucleus appears
to be the most critical area in the integration of multiple peripheral signals.
Among these signals, those originating from the white adipose tissue and the
gastrointestinal tract are known to be involved in the regulation of food intake.
The present paper focuses on adiponectin, an adipokine secreted by white
adipose tissue, which is reported to have a role in the control of feeding by acting
centrally. The recent observation that adiponectin is also able to influence gastric
motility raises the question of whether this action represents an additional
peripheral mechanism that concurs with the central effects of the hormone on
food intake. This possibility, which represents an emerging aspect correlating the
central and peripheral effects of adiponectin in the hunger-satiety cycle, is
discussed in the present paper.
Key words: Adipokines; Adiponectin; Adipose tissue; Food intake; Gastric motility;
Satiety signals
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Core tip: Central structures involved in the regulation of food intake receive and integrate
signals from peripheral organs, including white adipose tissue. This paper summarizes
the main findings on the influence of adiponectin, a pleiotropic hormone secreted by
adipocytes, on food intake. In addition to its central actions, adiponectin has been
recently reported to cause gastric motor changes known to be peripheral signals
implicated in the hunger-satiety cycle. In this light, we discuss the potential role of
adiponectin as a peripheral signal in the signaling network underlying hunger and satiety.
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The regulation of food intake consists of complex signals that allow the maintenance
of energy and nutrient balance. Several neurotransmitters that act at the central level
are  involved  in  energy  homeostasis  by  regulating  food  intake  and/or  energy
expenditure. A number of pathological conditions may lead to a loss of this control.
This can be observed in obesity, various metabolic diseases or eating disorders, where
the signaling systems that underlie appetite control are dysregulated and not yet fully
clarified. Therefore, it is important to elucidate the role of any single actor in this
extremely complex mechanism that could largely benefit the pathophysiology and
treatment of obesity and eating disorders. However, due to the complexity of the
physiological mechanisms underlying the regulation of food intake, we attempt to
make a simplified synthesis of the main central structures and some of the main
peripheral signals involved in the regulation of food intake to provide the reader with
a better understanding of the topic discussed.
CENTRAL STRUCTURES INVOLVED IN THE REGULATION
OF FOOD INTAKE
In brief, central nervous system structures, the hypothalamus in particular, are able to
integrate signals of different nature through afferent and efferent pathways to and
from the brainstem as well as peripheral organs[1]. The arcuate hypothalamic nucleus
appears to be the most critical area in the integration of such signals, some of which
are prevalently involved in the control of energy homeostasis and others related to the
short-term regulation of food intake[2]. The arcuate hypothalamic nucleus contains
neurons  whose  activation  influences  food  intake  by  exerting  anorexigenic  or
orexigenic  effects.  Particularly,  the  activation  of  neurons  that  express  pro-
opiomelanocortin (POMC), a precursor for many peptides, leads to a decrease in food
intake.  In  contrast,  the  stimulation  of  adjacent  neurons,  which  synthesize
neuropeptide Y (NPY) and agouti-related peptide, is known to cause an increase in
food intake. These two systems influence each other in opposite ways. The arcuate
hypothalamic nucleus represents the main integrative center of signals coming either
from  other  hypothalamic  areas  involved  in  feeding  behavior  (such  as  the
paraventricular nucleus, the dorsomedial nucleus and the lateral nucleus) or from
extra hypothalamic areas[3], such as the nucleus tractus solitaris. The latter receives
signals from the periphery and transmits them to the hypothalamus.
PERIPHERAL SIGNALS INVOLVED IN THE REGULATION OF
FOOD INTAKE: THE ROLE OF THE GASTROINTESTINAL
TRACT AND ADIPOSE TISSUE
There are many signals of both neural and hormonal nature that originate from the
periphery and are able to modulate feeding. In particular, the gastrointestinal tract is a
source  of  signals  able  to  influence  food intake  either  through the  release  of  gut
hormones or through gastrointestinal motor changes[4]. The latter could modify the
activity of the vagal afferent fibers, which send signals to the hypothalamic regions
through the interposition of the nucleus tractus solitaris.  Gut hormones,  such as
cholecystokinin, glucagon-like peptide-1, ghrelin and peptide tyrosine tyrosine, can
reach the brain by entering the systemic circulation and may also send signals to the
central structures by stimulating receptors present on vagal afferent neurons of the
gut mucosa[5].
Gastrointestinal  motor  changes,  particularly  those related to  the stomach,  are
recognized as key mediators of the hunger-satiety cycle. Gastric accommodation as
well as gastric emptying indeed play a significant role in the regulation of stomach
distension[6]. The latter has been shown to trigger stretch and tension, thus stimulating
mechanosensitive receptors. These, in turn, transmit their information via the afferent
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nerves[7,8] to several brain areas[9]. It is known that the tone of the gastric proximal
portion decreases during food intake. This process of active relaxation is mediated by
different parasympathetic reflex pathways, which lead to a decrease in contractile
cholinergic input and an increase in nitric oxide release[10]. Several studies reported
that the delay of gastric emptying, physiologically or artificially induced, and hence
the  dilation  of  the  gastric  wall  are  related to  an  increase  in  satiety  feelings  and
fullness, leading to food intake termination[11-13]. Interestingly, obese people showed
enhanced gastric emptying, whereas a subgroup of patients with anorexia nervosa
had significantly delayed gastric emptying[14,15]. Moreover, several studies combining
ultrasound and scintigraphy experiments  found an inverse  correlation  between
satiety and gastric distension/emptying[16-18].
Evidence exists that gastric distension-induced satiety can also be regulated by
some anorexigenic gut hormones (e.g., cholecystokinin and glucagon-like peptide-1),
which induce gastric distension and inhibit gastric emptying (and at the same time
increase gastric compliance). Such effects on gastric motility can contribute to their
effects on inducing satiety[19].
In this regard, several hormones, not only from the gastrointestinal tract but also
from other  organs,  such  as  white  adipose  tissue  (WAT),  have  been  reported  to
modulate appetite in humans[20]. WAT secretes adipokines and bioactive signaling
molecules[21-23]; thus, it is a part of the endocrine signaling system. This is the reason
why WAT cannot be thought of as an inactive organ but rather an endocrine organ.
Adipose tissue has complex interactions with the brain and peripheral organs and
plays  an  active  role  in  energy homeostasis  and several  other  processes[24,25].  For
instance, it controls the hunger-satiety cycle by providing hormonal signals about
energy stores to the brain via adipokines. Among them, in addition to leptin, whose
effects have been extensively investigated, adiponectin has also been reported to have
a role in regulating feeding behavior by sending signals to the hypothalamus[26].
ADIPONECTIN: CENTRAL ACTIONS IN THE REGULATION
OF FOOD INTAKE AND EFFECTS ON GASTRIC MOTILITY
Among adipokines, adiponectin has recently attracted much attention because of its
multiple  peripheral  actions:  It  seems  to  be  implicated  in  several  physiological
conditions  and  to  have  a  significant  role  in  the  maintenance  of  whole-body
homeostasis[27]. Moreover, adiponectin has been reported to exert numerous beneficial
effects as an antidiabetic, anti-atherosclerotic, antiapoptotic and anti-inflammatory
agent in both animals and humans[28,29]. The hormone has also been shown to have a
role  in  suppressing  lipogenesis  and  gluconeogenesis  and  to  increase  fatty  acid
oxidation and energy consumption[30].
Adiponectin  is  one  of  the  most  concentrated  hormones  in  plasma.  However,
despite  its  abundance,  circulating  adiponectin  plasma  concentrations  change
significantly[27] in a number of health and pathological conditions. In fact, a peculiar
feature of adiponectin is the inverse correlation of its circulating concentrations with
weight,  waist  circumference,  body mass index and obesity[31,32].  In  this  regard,  a
significant increase in adiponectin concentration in adipose tissue and plasma has
been described after  caloric  restriction or bariatric  surgery in obese subjects[33,34].
However,  the  mechanisms  underlying  obesity-associated  reductions  in  plasma
adiponectin concentrations have not yet been elucidated in detail.
In addition to peripheral actions, adiponectin has also been reported to exert central
actions in the regulation of food intake, but they are still controversial. Nonetheless,
the presence of adiponectin receptors has been proven in different regions of the
human brain[35,36], including the hypothalamic arcuate and lateral nuclei[37].
Adiponectin receptors (AdipoR1, AdipoR2, and T-cadherin) are indeed expressed
in the brain as  well  as  in the peripheral  tissues and show different  affinities  for
specific adiponectin isoforms, i.e., trimeric, hexameric, and high-molecular-weight
multimeric  isoforms[38].  Posttranslational  modifications  are  important  for  the
determination of adiponectin functionality since different isoforms of adiponectin
exhibit different biological activities. In particular, trimeric and hexameric forms are
reported  to  be  those  mainly  involved  in  the  central  regulation  of  food  intake.
Hexamers and high-molecular-weight adiponectin oligomers have been proposed to
bind  to  the  T-cadherin  receptor  in  the  brain,  even  if  their  interaction  remains
unclear[38,39]. Although AdipoR1 and AdipoR2 are both highly expressed in various
brain areas, only hypothalamic AdipoR1 has been suggested to mediate adiponectin
regulation of food intake and energy expenditure in mice[35].  A simplified scheme
illustrating the main central and peripheral effects of adiponectin and the related
receptors involved is reported in Figure 1.
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Figure 1
Figure 1  Simplified scheme summarizing some of the main adiponectin central and peripheral effects and the related receptors involved. The scheme is
based on the current knowledge and illustrates our hypothesis (orange arrow) concerning an additional peripheral mechanism through which adiponectin may
influence food intake at the central level. The receptor that seems to be mostly activated for the related effect is indicated in bold. 1indicates controversial results.
Whether different isoforms of adiponectin enter the brain has long been a debated
issue, but recent literature has reported that numerous adipokines are indeed able to
pass  through  the  blood-brain  barrier  and  act  right  on  the  brain[40].  Specifically,
adiponectin can cross the blood-brain barrier and can also be secreted locally in the
brain tissue[41], likely leading to different biological effects[38,40]. In particular, some
adiponectin isoforms (trimeric and hexameric) are indeed able to reach the brain and
hypothalamic centers[40]  to interact with the areas that control hunger and satiety.
Although this is a very exciting finding, many other aspects remain to be solved,
primarily whether adiponectin exerts anorexigenic or orexigenic effects.
Notwithstanding an early observation of Qi and coworkers[42], who reported no
central effects of adiponectin on food intake in mice, numerous subsequent studies
indeed refer to its ability to influence feeding by acting on hypothalamic nuclei. In this
view, Kubota et al[35] observed that full-length adiponectin, intravenously injected in
mice, enhanced adenosine monophosphate-activated protein kinase activity in the
arcuate hypothalamus[43]  via  AdipoR1, thus promoting food intake during fasting.
Contrasting results have been reported by Coope et al[26],  who demonstrated that
direct intracerebroventricular injection of adiponectin in fasted rats induced a dose-
related reduction in food intake. This effect was abolished following the inhibition of
AdipoR1 but not AdipoR2. Coope et al[26] proposed that the discrepancy between their
results and those obtained by Kubota et al[35] could be related to the different protocols
employed. In fact, the perfusion of the hormone through the jugular vein[35] did not
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take into account that adiponectin may not be able to easily pass through the blood-
brain barrier according to its different isoforms[5]. As a matter of fact, only the trimer
and low-molecular-weight hexamer have been detected in the human cerebrospinal
fluid, with the adiponectin trimer being the predominant oligomer[38]. This also gives a
possible explanation for the lack of effects observed by Qi et al[42]. Indeed, a reduction
in food intake has been recently observed following intracerebroventricular injection
of adiponectin in rats[44], in agreement with the above-reported results by Coope and
coworkers[26].
The effects  of  adiponectin on food intake and hypothalamic neuronal  activity
appear  to  also  be  related  to  different  nutritional  states  and  glucose  plasma
concentrations.  In  this  view,  electrophysiological  experiments  highlight  that
adiponectin  inhibits  NPY  neurons  and  activates  POMC  neurons  in  a  pho-
sphoinositide-3-kinase-dependent and activated protein kinase-independent manner
at various physiological glucose levels[45]. Two other recent studies[46,47] showed that
intracerebroventricular  injection  of  adiponectin  in  mice  influences  feeding  and
activates POMC neurons in relation to low or high glucose concentrations, whereas
the inhibitory action on NPY neurons is glucose-independent. These results proposed
an exciting new role for adiponectin as an attenuator of the effect of changes in the
glucose level on POMC neuron activity and feeding behavior.
Moreover, many substances that act centrally to regulate food intake are also able
to exert their effects at the gastrointestinal smooth muscle level. Among these, leptin
is one of the best characterized[48].  However, notwithstanding the above-reported
effects of adiponectin in the hunger-satiety cycle at the central level, no data were
present  in  the  literature  about  its  possible  peripheral  effects  on gastrointestinal
motility  until  recently.  The  ability  of  the  hormone  to  influence  the  mechanical
responses in strips from the mouse gastric fundus has been recently reported, and the
expression of both AdipoR1 and AdipoR2 receptors in these preparations has been
revealed[49].  Particularly,  a  neuromodulatory  action  for  the  hormone  has  been
suggested  due  to  its  ability  to  reduce  the  amplitude  of  the  neurally  induced
contractile responses and to enhance that of the relaxant ones (likely through the
involvement  of  the  nitric  oxide  pathway).  Interestingly,  in  addition  to  its
neuromodulatory action, adiponectin is capable of inducing gastric motor changes
through a direct relaxant effect on smooth muscle[49]. Likewise, electrophysiological
investigations[50]  indicate the ability of  the hormone to hyperpolarize the resting
membrane potential, suggesting a reduction of gastric smooth muscle cell excitability
and thus an inhibitory action on excitation-contraction coupling.
CONCLUSION
All the above considerations indicate that adiponectin may have an additional effect
on the regulation of food intake by inducing gastric motor changes. The depressant
actions  on the  gastric  muscle  exerted by adiponectin  may indeed be directed to
facilitate  relaxation,  which  may  lead  to  gastric  wall  distension,  known  to  be  a
peripheral satiety signal. Thus, the most attractive hypothesis is certainly that such
adiponectin effects may be truly regarded as a reinforcing peripheral mechanism
engaged by the hormone itself to concur with its central anorexigenic effects. Going a
step further, we can speculate that the depressant actions of the hormone on gastric
motility may also cause delayed gastric emptying, thus concurring with an increase in
satiety feelings and fullness, leading to food intake termination. With this in mind, we
can hypothesize the existence of a link between the depressant peripheral effects
exerted by adiponectin at the gastric level and its central anorexigenic effects.
However, it must be remembered that most of the studies have been carried out in
animals. Both central and peripheral effects of adiponectin in the regulation of food
intake certainly deserve to be further investigated from a translational perspective.
Dysfunction in generating signals or in the interpretation of these signals by the brain
may indeed lead to obesity and/or eating disorders.
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